99 related articles for article (PubMed ID: 21166629)
1. 3-Chlorotyrosine in sputum of COPD patients: relationship with airway inflammation.
O'Donnell C; Newbold P; White P; Thong B; Stone H; Stockley RA
COPD; 2010 Dec; 7(6):411-7. PubMed ID: 21166629
[TBL] [Abstract][Full Text] [Related]
2. [Expressions of cyclooxygenase-2 and matrix metalloproteinase-2 and airflow obstruction in patients with chronic obstructive pulmonary disease].
Chen Y; Chen P
Zhonghua Jie He He Hu Xi Za Zhi; 2005 May; 28(5):324-7. PubMed ID: 15949313
[TBL] [Abstract][Full Text] [Related]
3. Comparison of cellular and biochemical markers of airway inflammation in patients with mild-to-moderate asthma and chronic obstructive pulmonary disease: an induced sputum and bronchoalveolar lavage fluid study.
Gorska K; Krenke R; Domagala-Kulawik J; Korczynski P; Nejman-Gryz P; Kosciuch J; Hildebrand K; Chazan R
J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():271-83. PubMed ID: 19218651
[TBL] [Abstract][Full Text] [Related]
4. Repeatability of inflammatory parameters in induced sputum of COPD patients.
Boorsma M; Lutter R; van de Pol MA; Out TA; Jansen HM; Jonkers RE
COPD; 2007 Dec; 4(4):321-9. PubMed ID: 18027159
[TBL] [Abstract][Full Text] [Related]
5. Nitrosative stress in the bronchial mucosa of severe chronic obstructive pulmonary disease.
Ricciardolo FL; Caramori G; Ito K; Capelli A; Brun P; Abatangelo G; Papi A; Chung KF; Adcock I; Barnes PJ; Donner CF; Rossi A; Di Stefano A
J Allergy Clin Immunol; 2005 Nov; 116(5):1028-35. PubMed ID: 16275371
[TBL] [Abstract][Full Text] [Related]
6. [The change of concentration of endothelin derived from alveolar macrophages and in induced sputum in patients with chronic bronchitis].
Peng H; Chen P; Cai S
Zhonghua Jie He He Hu Xi Za Zhi; 2001 Jun; 24(6):351-4. PubMed ID: 11802988
[TBL] [Abstract][Full Text] [Related]
7. [Metalloproteinase-9/tissue inhibitor of metalloproteinase-1 in induced sputum in patients with asthma and chronic obstructive pulmonary disease and their relationship to airway inflammation and airflow limitation].
Xin XF; Zhao M; Li ZL; Song Y; Shi Y
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Mar; 30(3):192-6. PubMed ID: 17572998
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-18 in induced sputum: association with lung function in chronic obstructive pulmonary disease.
Rovina N; Dima E; Gerassimou C; Kollintza A; Gratziou C; Roussos C
Respir Med; 2009 Jul; 103(7):1056-62. PubMed ID: 19208460
[TBL] [Abstract][Full Text] [Related]
9. [Expression and significance of beta(2)-adrenoreceptor in inflammatory cells of patients with chronic obstructive pulmonary disease].
Zhu WJ; He B; Xu M
Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(30):2099-102. PubMed ID: 19080468
[TBL] [Abstract][Full Text] [Related]
10. Local inflammation occurs before systemic inflammation in patients with COPD.
He Z; Chen Y; Chen P; Wu G; Cai S
Respirology; 2010 Apr; 15(3):478-84. PubMed ID: 20210891
[TBL] [Abstract][Full Text] [Related]
11. [Changes of anaphylatoxin C5a in chronic obstructive pulmonary disease and the relationship with systemic and local inflammation].
Zhang J; Yao WZ; Sun YC
Zhonghua Jie He He Hu Xi Za Zhi; 2008 May; 31(5):356-9. PubMed ID: 18953960
[TBL] [Abstract][Full Text] [Related]
12. Sputum biomarker profiles in cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD) and association between pulmonary function.
Eickmeier O; Huebner M; Herrmann E; Zissler U; Rosewich M; Baer PC; Buhl R; Schmitt-Grohé S; Zielen S; Schubert R
Cytokine; 2010 May; 50(2):152-7. PubMed ID: 20181491
[TBL] [Abstract][Full Text] [Related]
13. [The expression and implications of human alpha-defensin 1-3 in serum and induced sputum in patients with chronic obstructive pulmonary disease].
Wang Z; Yao WZ; Xia GG; Sun DJ
Zhonghua Jie He He Hu Xi Za Zhi; 2008 Jun; 31(6):410-3. PubMed ID: 19031798
[TBL] [Abstract][Full Text] [Related]
14. Exhaled air molecular profiling in relation to inflammatory subtype and activity in COPD.
Fens N; de Nijs SB; Peters S; Dekker T; Knobel HH; Vink TJ; Willard NP; Zwinderman AH; Krouwels FH; Janssen HG; Lutter R; Sterk PJ
Eur Respir J; 2011 Dec; 38(6):1301-9. PubMed ID: 21700610
[TBL] [Abstract][Full Text] [Related]
15. [Higher levels of urokinase plasminogen activator system components in the airways of chronic obstructive pulmonary disease patients].
Xiao W; Tong WL; Ma DD
Zhonghua Jie He He Hu Xi Za Zhi; 2006 Nov; 29(11):723-6. PubMed ID: 17327049
[TBL] [Abstract][Full Text] [Related]
16. Loss of 3-chlorotyrosine by inflammatory oxidants: implications for the use of 3-chlorotyrosine as a bio-marker in vivo.
Whiteman M; Spencer JP
Biochem Biophys Res Commun; 2008 Jun; 371(1):50-3. PubMed ID: 18405660
[TBL] [Abstract][Full Text] [Related]
17. Granulocyte inflammatory markers and airway infection during acute exacerbation of chronic obstructive pulmonary disease.
Aaron SD; Angel JB; Lunau M; Wright K; Fex C; Le Saux N; Dales RE
Am J Respir Crit Care Med; 2001 Feb; 163(2):349-55. PubMed ID: 11179105
[TBL] [Abstract][Full Text] [Related]
18. Inter-relationships between inflammatory markers in patients with stable COPD with bronchitis: intra-patient and inter-patient variability.
Sapey E; Bayley D; Ahmad A; Newbold P; Snell N; Stockley RA
Thorax; 2008 Jun; 63(6):493-9. PubMed ID: 18057097
[TBL] [Abstract][Full Text] [Related]
19. [Correlations between chymase activity, levels of tryptase, and eotaxin in the sputum of patients with chronic obstructive pulmonary disease and their clinical implications].
Zhang XJ; He SH; Xie H; Wei JF; Liu CT
Zhonghua Jie He He Hu Xi Za Zhi; 2004 Oct; 27(10):649-53. PubMed ID: 16200864
[TBL] [Abstract][Full Text] [Related]
20. Serum ECP and MPO are increased during exacerbations of chronic bronchitis with airway obstruction.
Fiorini G; Crespi S; Rinaldi M; Oberti E; Vigorelli R; Palmieri G
Biomed Pharmacother; 2000 Jun; 54(5):274-8. PubMed ID: 10917466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
